锥光束乳腺CT的诊断准确性:系统评价与诊断性Meta分析
该系统评价与诊断性Meta分析共纳入6项研究、559例女性患者,评估锥光束乳腺CT鉴别乳腺良恶性病变的敏感度和特异度。增强锥光束乳腺CT的汇总敏感度0.899、特异度0.788、部分AUC 0.869,均优于平扫锥光束乳腺CT(敏感度0.789、特异度0.697、部分AUC 0.817)。增强锥光束乳腺CT的诊断准确性在数值上与已发表的乳腺MRI Meta分析结果(敏感度0.9、特异度0.72)相当。
要点
- 增强锥光束乳腺CT汇总敏感度0.899、特异度0.788,诊断准确性优于平扫(敏感度0.789、特异度0.697)。
- 增强锥光束乳腺CT诊断准确性在数值上与乳腺MRI Meta分析结果(敏感度0.9、特异度0.72)相当。
- 6项研究中4项纳入致密和极致密乳腺且微钙化比例高,平扫与增强扫描的汇总结果均存在研究间异质性。
核心结论
- 现有证据倾向于显示增强锥光束乳腺CT在敏感度、特异度和部分AUC方面均优于平扫锥光束乳腺CT。
- 增强锥光束乳腺CT的诊断准确性在数值上与已发表的乳腺MRI Meta分析结果(敏感度0.9、特异度0.72)相当,可能作为有MRI禁忌证患者的潜在影像替代选择。
研究设计与样本
- 系统评价与诊断性Meta分析,检索EMBASE、MEDLINE和CENTRAL数据库。
- 共筛选362项研究,最终纳入6项研究、559例患者。
- 所有研究于2015年至2018年间开展,评估女性受试者。
- 采用双变量方法联合建模敏感度和特异度,计算汇总受试者工作特征曲线下面积(AUC)。
- 所有分析分别针对平扫锥光束乳腺CT和增强锥光束乳腺CT进行。
关键影像表现/征象
- 6项研究中有4项纳入致密和极致密乳腺,且微钙化比例高。
诊断标准与关键数值
- 平扫锥光束乳腺CT:汇总敏感度0.789(95%CI:0.66-0.89),汇总特异度0.697(95%CI:0.471-0.851),部分AUC为0.817。
- 增强锥光束乳腺CT:汇总敏感度0.899(95%CI:0.785-0.956),汇总特异度0.788(95%CI:0.709-0.85),部分AUC为0.869。
- 平扫锥光束乳腺CT敏感度与特异度的研究间异质性均显著(I²=89.4%、I²=94.7%,均p<0.001)。
- 增强锥光束乳腺CT敏感度与特异度的研究间异质性为中等且未达统计学显著(I²=57.3%,p=0.0527;I²=53.1%,p=0.0738)。
临床应用与阅片要点
- 作者认为,评估乳腺病变应使用增强锥光束乳腺CT而非平扫锥光束乳腺CT,因其诊断准确性更高。
- 增强锥光束乳腺CT的诊断性能与已发表的乳腺MRI结果相当,作者提出其可能作为有MRI禁忌证患者的潜在影像替代选择。
局限性
- 平扫锥光束乳腺CT的汇总敏感度和特异度均存在显著的研究间异质性(I²=89.4%、I²=94.7%,均p<0.001)。
- 增强锥光束乳腺CT的汇总敏感度和特异度存在中等程度的研究间异质性(I²=57.3%,p=0.0527;I²=53.1%,p=0.0738)。
- 6项研究中仅4项纳入致密和极致密乳腺且微钙化比例高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To review the published evidence on cone-beam breast computed tomography (CBBCT) and summarize its diagnostic accuracy for breast lesion assessment.
MATERIALS AND METHODS: A systematic literature search was conducted using the EMBASE, MEDLINE and CENTRAL libraries. Studies were included if reporting sensitivity and specificity for discrimination of benign and malignant breast lesions via breast CT. Sensitivity and specificity were jointly modeled using a bivariate approach calculating summary areas under the receiver-operating characteristics curve (AUC). All analyses were separately performed for non-contrast and contrast-enhanced CBBCT (NC-CBBCT, CE-CBBCT).
RESULTS: A total of 362 studies were screened, of which 6 with 559 patients were included. All studies were conducted between 2015 and 2018 and evaluated female participants. Four of six studies included dense and very dense breasts with a high proportion of microcalcifications. For NC-CBBCT, pooled sensitivity was 0.789 (95% CI: 0.66-0.89) and pooled specificity was 0.697 (95% CI: 0.471-0.851), both showing considerable significant between-study heterogeneity (I2 = 89.4%, I2 = 94.7%, both p < 0.001). Partial AUC for NC-CBBCT was 0.817. For CE-CBBCT, pooled sensitivity was 0.899 (95% CI: 0.785-0.956) and pooled specificity was 0.788 (95% CI: 0.709-0.85), both exhibiting non-significant moderate between-study heterogeneity (I2 = 57.3%, p = 0.0527; I2 = 53.1%, p = 0.0738). Partial AUC for CE-CBBCT was 0.869.
CONCLUSION: The evidence available for CBBCT tends to show superior diagnostic performance for CE-CBBCT over NC-CBBCT regarding sensitivity, specificity and partial AUC. Diagnostic accuracy of CE-CBBCT was numerically comparable to that of breast MRI with meta-analyses reporting sensitivity of 0.9 and specificity of 0.72.
KEY POINTS: • CE-CBBCT rather than NC-CBBCT should be used for assessment of breast lesions for its higher diagnostic accuracy. • CE-CBBCT diagnostic performance was comparable to published results on breast MRI, thus qualifying CE-CBBCT as a potential imaging alternative for patients with MRI contraindications.
引用
- Uhlig J, Uhlig A, Biggemann L, et al. Diagnostic accuracy of cone-beam breast computed tomography: a systematic review and diagnostic meta-analysis. Eur Radiol. 2018. PMID: 30255249. doi:10.1007/s00330-018-5711-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。